BACKGROUND: Nosocomial bloodstream infections (NBSIs) occur frequently in neonatal intensive care units (NICUs) and are associated with substantial morbidity and mortality. Little has been published regarding variation in NBSI among institutions. OBJECTIVE: To determine NBSI incidence among six NICUs and to explore how much variation is explained by patient characteristics and NICU practice patterns. METHODS: From October, 1994, to June, 1996, six regional NICUs prospectively abstracted clinical records of all neonates weighing <1,500 g. Occurrence of NBSI, defined as first positive culture occurring >48 h after admission, was analyzed in relation to baseline patient characteristics and several common therapeutic interventions. Variables significant in univariate analyses were analyzed by Cox proportional hazards regression. RESULTS: There were 258 NBSIs (incidence, 19.1%) among 1,354 inborn first admissions. Incidence varied significantly by site, from 8.5 to 42%. Birth weight, Broviac catheter use and parenteral nutrition were significantly associated with NBSI (P < 0.05). When controlling for these variables interinstitutional variation in NBSI occurrence decreased but remained significant. CONCLUSIONS: Neonatal NBSI incidence varies substantially among institutions despite adjustment for length of stay and some known risk factors. The uses of Broviac catheters and especially intravenous nutrition supplements were significant determinants of NBSI risk.
BACKGROUND:Nosocomial bloodstream infections (NBSIs) occur frequently in neonatal intensive care units (NICUs) and are associated with substantial morbidity and mortality. Little has been published regarding variation in NBSI among institutions. OBJECTIVE: To determine NBSI incidence among six NICUs and to explore how much variation is explained by patient characteristics and NICU practice patterns. METHODS: From October, 1994, to June, 1996, six regional NICUs prospectively abstracted clinical records of all neonates weighing <1,500 g. Occurrence of NBSI, defined as first positive culture occurring >48 h after admission, was analyzed in relation to baseline patient characteristics and several common therapeutic interventions. Variables significant in univariate analyses were analyzed by Cox proportional hazards regression. RESULTS: There were 258 NBSIs (incidence, 19.1%) among 1,354 inborn first admissions. Incidence varied significantly by site, from 8.5 to 42%. Birth weight, Broviac catheter use and parenteral nutrition were significantly associated with NBSI (P < 0.05). When controlling for these variables interinstitutional variation in NBSI occurrence decreased but remained significant. CONCLUSIONS:Neonatal NBSI incidence varies substantially among institutions despite adjustment for length of stay and some known risk factors. The uses of Broviac catheters and especially intravenous nutrition supplements were significant determinants of NBSI risk.
Authors: Christoph P Hornik; Daniel K Benjamin; Kristian C Becker; Daniel K Benjamin; Jennifer Li; Reese H Clark; Michael Cohen-Wolkowiez; P Brian Smith Journal: Pediatr Infect Dis J Date: 2012-08 Impact factor: 2.129
Authors: Jochen Profit; Marie C McCormick; Gabriel J Escobar; Douglas K Richardson; Zheng Zheng; Kim Coleman-Phox; Rebecca Roberts; John A F Zupancic Journal: Pediatrics Date: 2007-02 Impact factor: 7.124
Authors: Jasmine Chong; Caroline Quach; Ana C Blanchard; Philippe Guillaume Poliquin; George R Golding; Céline Laferrière; Simon Lévesque Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191
Authors: Daniel S Tawfik; John Bryan Sexton; Kathryn C Adair; Heather C Kaplan; Jochen Profit Journal: Clin Perinatol Date: 2017-07-08 Impact factor: 3.430
Authors: Jong Hee Hwang; Chang Won Choi; Yun Sil Chang; Yon Ho Choe; Won Soon Park; Son Moon Shin; Munhyang Lee; Sang Il Lee Journal: J Korean Med Sci Date: 2005-04 Impact factor: 2.153
Authors: Leonard E Weisman; Helen M Thackray; Joseph A Garcia-Prats; Mirjana Nesin; Joseph H Schneider; Jennifer Fretz; John F Kokai-Kun; James J Mond; William G Kramer; Gerald W Fischer Journal: Antimicrob Agents Chemother Date: 2009-04-20 Impact factor: 5.191